Discovery of molecular glues that bind FKBP12 and structurally distinct targets using DNA-encoded libraries

Molecular glues are small molecules that engage their target and presenter proteins cooperatively. FKBP12 molecular glues (FK506 and rapamycin) were discovered several decades ago and have been used clinically, but our understanding of the breadth of FKBP12 molecular glues and targets has yet to be fully revealed. To expand the target classes of FKBP12 molecular glues, we construct and screen a multi-million-member non-macrocyclic FKBP12-ligand DNA-encoded library using 25 structurally distinct proteins. Synthesis and validation of select hits in biophysical and cell-based assays confirm FKBP12-dependent molecular-glue recruitment to bromodomain-containing protein 9 (BRD9) and quinoid dihydropteridine reductase (QDPR). One glue shows no measurable binding to QDPR alone but has appreciable binding in the presence of FKBP12 using either purified proteins or intact cells. The sites of recruitment are characterized with mutational analysis, competition-based methods and X-ray crystallography. The results of this study confirm that FKBP12-binding DELs can yield molecular glues generating highly selective FKBP12-target protein interactions.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2026-04-22
DOI
https://doi.org/10.1038/s41467-026-71512-x
Primary Topic
Signaling Pathways in Disease
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Discovery of molecular glues that bind FKBP12 and structurally distinct targets using DNA-encoded libraries

Simone Bonazzi, Stuart L. Schreiber, Trevor A. Zandi, Frédéric J. Zécri et al.
Nature Communications
Signaling Pathways in Disease
article

Discovery of molecular glues that bind FKBP12 and structurally distinct targets using DNA-encoded libraries

Simone Bonazzi, Stuart L. Schreiber, Trevor A. Zandi, Frédéric J. Zécri, Gregory A. Michaud, Zher Yin Tan, Jessica Viscomi, Bingqi Tong, Karl Gunderson, Michael J. Romanowski
article en

Abstract

Molecular glues are small molecules that engage their target and presenter proteins cooperatively. FKBP12 molecular glues (FK506 and rapamycin) were discovered several decades ago and have been used clinically, but our understanding of the breadth of FKBP12 molecular glues and targets has yet to be fully revealed. To expand the target classes of FKBP12 molecular glues, we construct and screen a multi-million-member non-macrocyclic FKBP12-ligand DNA-encoded library using 25 structurally distinct proteins. Synthesis and validation of select hits in biophysical and cell-based assays confirm FKBP12-dependent molecular-glue recruitment to bromodomain-containing protein 9 (BRD9) and quinoid dihydropteridine reductase (QDPR). One glue shows no measurable binding to QDPR alone but has appreciable binding in the presence of FKBP12 using either purified proteins or intact cells. The sites of recruitment are characterized with mutational analysis, competition-based methods and X-ray crystallography. The results of this study confirm that FKBP12-binding DELs can yield molecular glues generating highly selective FKBP12-target protein interactions.

Nature Communications
Broad Institute (US), Novartis (Switzerland) (CH), Harvard University (US), Novartis (China) (CN), Dana-Farber Cancer Institute (US), Novartis (United States) (US)
National Institutes of Health
Openalex Percentile: Top 10%
Signaling Pathways in Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.